Galli M - Search Results

1

Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study.

Adorni F, Jesuthasan N, Perdixi E, Sojic A, Giacomelli A, Noale M, Trevisan C, Franchini M, Pieroni S, Cori L, Mastroianni CM, Bianchi F, Antonelli-Incalzi R, Maggi S, Galli M, Prinelli F, On Behalf Of The Epicovid Working Group. Adorni F, et al. Among authors: galli m. Int J Environ Res Public Health. 2022 Jan 24;19(3):1274. doi: 10.3390/ijerph19031274. Int J Environ Res Public Health. 2022. PMID: 35162295 Free PMC article. Clinical Trial.

2

Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy.

Gervasoni C, Ridolfo AL, Vaccarezza M, Parravicini C, Vago L, Adorni F, Cappelletti A, d'Arminio Monforte A, Galli M. Gervasoni C, et al. Among authors: galli m. Clin Infect Dis. 2002 Dec 15;35(12):1534-40. doi: 10.1086/344778. Epub 2002 Dec 2. Clin Infect Dis. 2002. PMID: 12471574

3

Increased CD36 expression on circulating monocytes during HIV infection.

Meroni L, Riva A, Morelli P, Galazzi M, Mologni D, Adorni F, Galli M. Meroni L, et al. Among authors: galli m. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):310-3. J Acquir Immune Defic Syndr. 2005. PMID: 15735450

4

Risk factors for HIV/AIDS in a low HIV prevalence site of sub-Saharan Africa.

Croce F, Fedeli P, Dahoma M, Dehò L, Ramsan M, Adorni F, Corvasce S, Galli M. Croce F, et al. Among authors: galli m. Trop Med Int Health. 2007 Sep;12(9):1011-7. doi: 10.1111/j.1365-3156.2007.01880.x. Trop Med Int Health. 2007. PMID: 17875012 Free article.

5

Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002.

Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C, Ridolfo AL. Antinori S, et al. Among authors: galli m. Am J Clin Pathol. 2009 Aug;132(2):221-7. doi: 10.1309/AJCPRAAE8LZ7DTNE. Am J Clin Pathol. 2009. PMID: 19605816

6

Prevalence and risk determinants of HIV-1 and HIV-2 infections in pregnant women in Bissau.

Gianelli E, Riva A, Rankin Bravo FA, Da Silva Te D, Mariani E, Casazza G, Scalamogna C, Bosisio O, Adorni F, Rusconi S, Galli M. Gianelli E, et al. Among authors: galli m. J Infect. 2010 Nov;61(5):391-8. doi: 10.1016/j.jinf.2010.08.012. Epub 2010 Sep 8. J Infect. 2010. PMID: 20831880 Free article.

7

Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results.

Ortu M, Vitiello P, Adorni F, Rossotti R, Di Vincenzo P, Vigano O, Galli M, Rusconi S. Ortu M, et al. Among authors: galli m. Curr HIV Res. 2011 Dec 1;9(8):625-9. doi: 10.2174/157016211798998790. Curr HIV Res. 2011. PMID: 22211659 Free article.

8

Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.

Ferraris L, Viganò O, Peri A, Tarkowski M, Milani G, Bonora S, Adorni F, Gervasoni C, Clementi E, Di Perri G, Galli M, Riva A. Ferraris L, et al. Among authors: galli m. J Antimicrob Chemother. 2012 Sep;67(9):2236-42. doi: 10.1093/jac/dks175. Epub 2012 Jun 2. J Antimicrob Chemother. 2012. PMID: 22661571 Clinical Trial.

9

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population.

Rusconi S, Giacomet V, Mameli C, Viganò A, Viganò O, Adorni F, Galli M, Zuccotti GV. Rusconi S, et al. Among authors: galli m. BMC Infect Dis. 2012 Aug 6;12:179. doi: 10.1186/1471-2334-12-179. BMC Infect Dis. 2012. PMID: 22866946 Free PMC article.

10

Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.

Franzetti M, Adorni F, Parravicini C, Vergani B, Antinori S, Milazzo L, Galli M, Ridolfo AL. Franzetti M, et al. Among authors: galli m. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):414-20. doi: 10.1097/QAI.0b013e318282a189. J Acquir Immune Defic Syndr. 2013. PMID: 23274934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,989 results

Search Page